While FDA guidance (“Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices”) states that ...
Long-term follow-up is a necessity for vaccine development, and is critical for establishing safety data, determining how ...
UC Berkeley School of Public Health researchers are collaborating with the FDA and industry to make drug clinical trials ...
For automated capture of end points, aims were to (1) develop and test methods to collect end point–defining image files for patients participating in clinical trials, (2) develop a data model and ...
In the last decade, the volume of clinical trial data has surged, presenting unprecedented challenges for sponsors and contract research organizations (CROs). The task of collecting, cleaning, ...
Please provide your email address to receive an email when new articles are posted on . Most patients supported the acceptability of an informed opt-out consent model for real-world data collection.
Clayton Irvine, PharmD, MBA, MS, explains that leveraging high-quality, real-world data; cross-institutional collaboration; standardized care pathways; advanced technologies; and integrated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results